A Single-Arm Biomarker-Based Phase II Trial of Savolitinib in Patients with Advanced Papillary Renal Cell Cancer
Toni K. Choueiri, Elizabeth Plimack, Hendrik-Tobias Arkenau, Eric Jonasch, Daniel Y. C. Heng, Thomas Powles, Melanie M. Frigault, Edwin Clark, Amir Handzel, Humphrey Gardner, Shethah Morgan, Laurence Albiges, Sumanta Kumar Pal
Event: Genitourinary Cancers Symposium sponsored by the American Society of Clinical Oncology (ASCO GU)
Abstract No: 436
Session: Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer
Date: Saturday, February 18, 2017
Time: 7:00 AM-7:55 AM and 11:30 AM-1:00 PM (EST)